Daily Digest: Last 24 Hours: Brain Aging, Driving Safety, and the Global Fight for Patient Access — March 05, 2026
Recent studies on cannabis cognitive aging older adults provide reassuring data about cognitive decline risks. Evidence shows THC blood levels poorly predict driving impairment. Patient access remains a critical issue in the U.S. and U.K. healthcare…
Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals
Washington state legislation now permits medical cannabis use in hospitals for terminally ill patients. This policy change supports symptom management in inpatient settings with proper authorization. Medical cannabis use in hospitals offers new options…
Daily Digest: Last 18 Hours: Cannabis Impairment Testing, Brain Aging, and the Race for Better Evidence — March 05, 2026
A synthesis of 6 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…
West Virginia House Approves Medical Cannabis Edibles Bill
West Virginia medical cannabis program expands to include edible formulations, offering patients improved access and treatment options. Edibles provide pharmacokinetic advantages for those with respiratory issues or needing longer symptom relief. This…
What a Major Study Reveals About Cannabis Use and Brain Aging
Cannabis use and brain aging is a complex relationship explored in a major study using large biobank datasets. The research suggests initial differences in brain age metrics among cannabis users but no straightforward harmful or protective effects. This…
Daily Digest: Last 48 Hours: Adolescent Risk, Aging Brains, and the Long Road to Pharmaceutical-Grade Cannabis — March 04, 2026
This digest highlights cannabis medicine maturity, focusing on age-stratified cannabis risks and recent advances. It covers cannabinoid hyperemesis syndrome and pharmaceutical-grade CBD development. The evolving regulatory landscape shapes clinical…
Daily Digest: Adolescent Risks and Pharmaceutical-Grade Cannabis Progress
This daily digest highlights pharmaceutical-grade CBD clinical trial development and adolescent cannabis exposure risks. Recent studies emphasize measurable harm from adolescent use. Meanwhile, cognitive aging research offers reassurance for older adults.
New Study Reveals How 35 Years of Excessive Drinking Impacts Brain
This study highlights chronic alcohol use endocannabinoid system disruption and its role in cognitive and psychiatric complications. Long-term excessive drinking dysregulates this system, impacting brain functions. Understanding this helps clinicians…
Daily Digest: Last 15 Hours: Pharmaceutical Standards, Cognitive Safety, and Policy Gaps — March 03, 2026
This digest highlights pharmaceutical standardization cannabinoid therapeutics as a key theme in recent cannabis research. It discusses clinical-grade cannabis and the gap between medicine and policy. The focus is on improving patient access through…